Jump to main navigation | Jump to sub navigation | Jump to SiteMap | Jump to Home Page |

Search | Disclaimer | Accessibility | Rule 26 | Site map |

Minster Pharmaceuticals

Our therapeutic focus

Investor relations

About us Background Our strategy

Our therapeutic focus Migraine Schizophrenia

Our products Overview Tonabersat Sabcomeline

Our team Board Scientific advisors Collaborators

Investor relations Rule 26 Reports & presentations Share price Major shareholders Advisors Corporate governance

News & Media RNS

Contact us Search Disclaimer Accessibility Rule 26

© 2007 Minster Pharmaceuticals plc. All Rights Reserved
Date last updated : 02/09/2008 15:34:23
This date pertains to all information administered by Minster Pharmaceuticals. The regulatory news and share price information are supplied by an external party.